Key Financial Figures (₹ lakhs)
- Total Income: ₹4,806.32 (FY26) vs ₹4,808.67 (FY25)
- Revenue from Operations: ₹4,743.61 (FY26) vs ₹4,785.33 (FY25)
- Profit Before Tax: ₹567.02 (FY26) vs ₹568.74 (FY25)
- Profit After Tax: ₹421.06 (FY26) vs ₹420.67 (FY25)
- Depreciation: ₹281.65 (FY26) vs ₹215.80 (FY25)
- Current Tax: ₹82.38 (FY26) vs ₹133.84 (FY25)
- Deferred Tax: ₹63.58 (FY26) vs ₹13.77 (FY25)
- Earnings Per Share: ₹3.09 (Basic and Diluted)
Operational Highlights
- Admissions: 4.2K+
- ER Patients: 3.7K+
- Robotic Surgeries: 100+
- Average Length of Stay: 2.6 days
- Total IPO Proceeds Utilized: ₹2,061.72 lakhs fully utilized as per objects:
- Capital Expenditure: ₹1,452.50 lakhs
- Issue Expenses: ₹225.94 lakhs
- General Corporate Purposes: ₹383.28 lakhs
Key Dates
- AGM Date: Friday, 18th September 2026 at 02:30 PM (IST)
- Record Date for AGM: 11th September 2026
- E-voting Period: 15th September 2026 (09:00 AM) to 17th September 2026 (05:00 PM)
- Financial Year: 1st April 2025 to 31st March 2026
AGM Agenda Items
Ordinary Business
1. Adoption of audited financial statements for FY 2025-26
2. Re-appointment of Mrs. Panneerselvam Jayalakshmi (DIN: 10692764) as Director retiring by rotation
3. Re-appointment of Mr. Karuppiah Saravanan (DIN: 10692765) as Director retiring by rotation
Special Business
4. Increase in Authorized Share Capital from ₹14 crores to ₹25 crores
5. Amendment of Memorandum of Association to add new objects:
- Providing administrative/operational support to medical colleges and healthcare institutions
- Software development and digital applications business
6. Alteration of Articles of Association
7. Approval of "Shanmuga Hospital Limited Employee Stock Option Plan 2026" for 3,50,000 options
8. Appointment of CS Anuradha as Secretarial Auditor for 5 years (FY 2026-27 to 2030-31)
Capital Structure
- Authorized Share Capital: ₹14,00,00,000 divided into 1,40,00,000 equity shares of ₹10 each
- Paid-up Share Capital: ₹13,61,30,000 divided into 1,36,13,000 equity shares of ₹10 each
- No bonus shares, buybacks, or rights issues during the year
Key Developments
- Successfully operationalized Da Vinci Xi Robotic Surgical System funded through IPO proceeds
- Maintained NABH accreditation and Nursing Excellence certification
- Received "Certificate of Recognition" at Times Healthcare Achievers - Tamil Nadu 2025
- Conducted 100+ robotic-assisted surgeries marking a significant milestone
- Continued community outreach through medical camps and CSR initiatives
CSR Activities
- Total CSR Obligation: ₹12,87,585 (2% of average net profit)
- Amount Spent: ₹12,94,322
- Focus Areas: Education, Preventive Healthcare, Community Development
- Initiatives: Digital learning resources, school safety infrastructure, medical camps
Board Composition
Managing Director: Dr Palaniappan Shanmugam Panneerselvam
Executive Director & CEO: Dr Panneerselvam Prabu Sankar
Executive Director: Mrs Panneerselvam Jayalakshmi
Non-Executive Director: Dr Dhandapani Priyadharshni
Non-Executive Director: Mr Karuppiah Saravanan
Independent Directors: CA Gowri, CS Bhoopathy Akilan, Mr Rajkumar Ashwin
Key Managerial Personnel
- CEO: Dr P. Prabu Sankar
- CFO: Mr Karthick
- Company Secretary & Compliance Officer: CS Kannan Anjana Maragatham
Related Party Transactions
Transactions with related parties including directors and their entities were in ordinary course of business at arm's length, primarily comprising:
- Professional fees to directors: ₹100.17 lakhs
- Purchase of medicines: ₹167.44 lakhs
- Rent payments: ₹54.07 lakhs
Employee Benefits
- Gratuity Liability: ₹30.06 lakhs (unfunded)
- Gratuity Expense: ₹18.26 lakhs
- Total Employees: 254 permanent employees
Internal Financial Controls
Company has adequate internal financial controls framework which were operating effectively during the year.
Forward-looking Statements
The Management Discussion & Analysis section contains forward-looking statements about industry outlook, growth opportunities, and company strategies subject to risks and uncertainties.